Bárbara Carreira
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 1
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 1
-
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 2
- Pharmaceutical Science top 10%
-
- Nanoplatforms for cancer theranostics 4
- Innovative Microfluidic and Catalytic Techniques Innovation 1
-
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 3
Bárbara Carreira
10 papers receiving 755 citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Biomaterials 178
- Infectious Diseases 185
- Immunology 160
- Pharmaceutical Science 43
- Biomedical Engineering 247
Countries citing papers authored by Bárbara Carreira
This map shows the geographic impact of Bárbara Carreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bárbara Carreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bárbara Carreira more than expected).
Fields of papers citing papers by Bárbara Carreira
This network shows the impact of papers produced by Bárbara Carreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bárbara Carreira. The network helps show where Bárbara Carreira may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bárbara Carreira, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 36 | |
| 6 | 2021 | 33 | |
| 7 | Current hurdles to the translation of nanomedicines from bench to the clinicbreakdown → | 2021 | 284 |
| 8 | 2020 | 249 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 52 | |
| 11 | 2017 | 75 | |
| 12 | 2016 | 11 |
About Bárbara Carreira
Bárbara Carreira is a scholar working on Immunology, Oncology and Biomedical Engineering, having authored 12 papers that have together received 765 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Nanoplatforms for cancer theranostics (4 papers), CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Biomaterials (178 citations), Infectious Diseases (185 citations) and Immunology (160 citations). Bárbara Carreira has collaborated with scholars based in Portugal, Israel and Spain. Frequent co-authors include Helena F. Florindo, Ronit Satchi‐Fainaro, Rita C. Acúrcio, Sabina Pozzi, Snežana Đorđević, Inmaculada Conejos‐Sánchez, Marı́a J. Vicent, María Medel, Ron Kleiner and Daniella Vaskovich‐Koubi. Their work appears in journals such as Journal of Controlled Release, Cancer Research, Advanced Therapeutics, Seminars in Immunology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.